Ординатура / Офтальмология / Учебные материалы / Clinical Diagnosis and Management of ocular trauma
.pdf
196 |
|
Clinical Diagnosis and Management of Ocular Trauma |
|
|
blunt head trauma. This is in contrast to direct TON, |
|
|
|
|
|
|
|
|
which results from an anatomical disruption of the optic |
|
|
|
nerve fibers. |
|
|
|
Patients can present with a variable degree of vision |
|
|
|
loss (decreased visual acuity, visual field abnormalities, |
|
|
|
or loss of color vision). Most cases (up to 60%) present |
|
|
|
with severe vision loss of light perception (LP) or |
|
|
|
worse. |
|
|
|
||
|
|
In the acute phase, the optic nerve usually appears |
|
|
|
normal on funduscopic examination, but optic nerve |
|
|
|
atrophy is often seen 3-6 weeks after the injury; so |
|
|
|
the clinical must be aware to perform periodical |
|
|
|
revisions of the traumatized eye during a long period |
|
|
|
of time. |
Fig. 31.7: Optic nerve avulsion |
|
|
|
|
|
|
Mechanisms of Injury |
|
|
|
There are two known forms of optic nerve injury: |
|
|
|
Indirect injury: In indirect TON cases, the injury to |
|
|
|
the axons is thought to be induced by shearing forces |
|
|
|
that are transmitted to the fibers or to the vascular |
|
|
|
supply of the nerve. Studies have shown that forces |
|
|
|
are transferred and concentrated in the area near |
|
|
|
the optic canal. The tight adherence of the optic |
|
|
|
nerve’s dural sheath to the periosteum within the optic |
|
|
|
canal is also thought to contribute to this segment |
|
|
|
of the nerve being extremely susceptible to the |
|
|
|
deformative stresses of the skull bones. Such injury |
|
|
|
leads to ischemic injury to the retinal ganglion |
|
|
|
cells within the optic canal. |
|
|
|
Direct injury: A secondary mechanism can result |
|
|
|
in optic nerve swelling after the occurrence the acute |
|
|
|
injury. The optic nerve swelling can exacerbate retinal |
|
|
|
ganglion cell degeneration by further compromising |
Fig. 31.8: Optic nerve atrophy |
|
|
the vascular blood supply, either through a rise in |
|
|
|
|
|
|
|
intraluminal pressure or reactive vasospasm. These |
of a bilateral TON, both pupils may be dilated and |
|
|
secondary mechanisms, in theory, form the rationale |
|
|
|
nonreactive to light if the injury is profound. |
|
|
|
for optic canal decompression via medical (e.g.steroids) |
|
|
|
At the funduscopic, because the location of the |
|
|
|
or surgical means (e.g. bony decompression). |
|
|
|
injury in most of the cases is within the posterior orbit |
|
|
|
|
|
|
|
Diagnosis |
or the optic canal, the optic disc typically appears |
|
|
normal on funduscopic examination on initial diagnosis. |
|
|
|
Even in an acute trauma setting, patients should have |
|
|
|
Optic nerve atrophy usually appears 3-4 weeks after |
|
|
|
a visual acuity assessment as soon as possible. If the |
the traumatic event, and the disc acquires a diffuse |
|
|
patient cannot read the top letter on the eye chart, |
pallor. Rarely, optic nerve changes can be seen with |
|
|
the visual acuity may be recorded with the following |
direct injuries to the retrobulbar section of the optic |
|
|
nomenclature; counting fingers vision, hand motion |
nerve, presenting as an avulsed optic nerve head or |
|
|
perception, light perception (LP), or no light perception |
optic disc swelling with surrounding hemorrhage |
|
|
(NLP), sometimes are the obtained lectures. |
(Figs 31.7 and 31.8). |
|
|
The pupil examination assesses for a relative or |
Computed Tomography of orbits, comparing both |
|
|
complete afferent pupillary defect. An eye with a |
optic nerves anatomy, are sometimes of great value, |
|
|
unilateral optic nerve injury will demonstrate an |
but even so, sometimes even in the presence of severe |
|
|
afferent papillary defect, verifying the presence of TON, |
optic nerve damage, the funduscopic and the radiologic |
|
|
but not excluding other diagnosis. In the rare cases |
findings can be normal. |
|
|
|
|
Management of Blunt Retinal Trauma |
|
197 |
|
Management |
velocity missile; it is the result of traumatic chorioretinal |
|
|
Steroids have been used in TON since the early 1980s; |
rupture followed by marked fibrovascular proliferation |
|
|
they are thought to provide neuroprotection in |
with variable replacement of the choroid and retina |
|
|
traumatic central nervous system injury through their |
with no retinal detachment. |
|
|
antioxidant properties and inhibition of free radical- |
Contusion force may lead to choroidal ruptures |
|
|
induced lipid peroxidation. Recent studies have |
with hyperplasia and migration of the retinal pigment |
|
|
demonstrated that the therapeutic role for cortico- |
epithelium into the retina and choroid, epiretinal |
|
|
steroids in the management of TON is unsubstantiated. |
membrane formation, loss of photoreceptors and |
|
|
If steroids are considered to be used in cases with |
marked atrophy of the optic nerve. |
|
|
concomitant traumatic brain injury, it must not be a |
|
|
|
decision of the ophthalmologist by it self; dangerous |
Diagnosis |
|
|
circumstances involving the central nervous system can |
The diagnosis should be established only based on |
|
|
be mascared. The use high or lower doses of steroids |
|
||
clear objective findings, a relative afferent pupillary |
|
||
is also not clearly defined by the literature as useful |
|
||
defect or an evoked visual response. The most |
|
||
for optic nerve protection. May be, as has been seen |
|
||
important factor in determining the force of injury is |
|
||
in other sections of this chapter, they can provide a |
|
||
the velocity. As higher the speed of the projectile object, |
|
||
placebo effect in the patient, family, but also in the |
|
||
the greater the tissue disruption at the impact zone |
|
||
physician. |
|
||
due to the delivered kinetic energy. The shock wave |
|
||
The indication for surgical therapy in indirect optic |
|
||
energy released by the projectile object is considered |
|
||
nerve trauma is to decompress it at the site of injury, |
|
||
as the main cause of choroidal and subsequently retinal |
|
||
which is often the intracanalicular segment. Surgical |
|
||
injury (Fig. 31.9). |
|
||
decompression is thought to help reduce optic nerve |
|
||
|
|
|
|
compression and subsequent vascular compromise that |
Treatment |
|
|
may occur as a result of the indirect injury. Another |
|
||
probably benefit of surgery that has been postulated, |
Retained intraorbital metallic foreign bodies may |
|
|
is to remove bone fragments that may be injuring on |
accompany chorioretinitis scleopetaria, commotio |
|
|
the optic nerve within the optic canal. However, no |
retinae, vitreous hemorrhages, or some other times |
|
|
randomized, controlled studies have been performed |
this entity can be presented alone; treatment of |
|
|
to evaluate the role of surgery in this disease. |
concomitant damage should be done. In the case of |
|
|
|
bullets, gun pellets, the usual management is |
|
|
Conclusions |
conservative due to the inert nature of this type of |
|
|
Traumatic optic neuropathy (TON) can lead to pro- |
metallic foreign bodies. There are considerable |
|
|
found visual loss from either indirect or direct |
reported cases with chorioretinitis sclopetaria due to |
|
|
mechanisms. The diagnosis can be made with |
bullet gun injuries; the characteristic pattern of |
|
|
accurate history taking and clinical examination, based |
choroidal and retinal changes caused by a high |
|
|
on the presence of visual loss and an accompanying |
velocity projectile object passing through the orbit, |
|
|
relative afferent pupillary defect. The optimal treatment |
in close proximity to the globe is usually seen in this |
|
|
for TON, however, remains debated among physicians. |
condition. |
|
|
Corticosteroids should not be used in cases with |
|
|
|
concomitant traumatic brain injury or in patients who |
|
|
|
present 8 hours or more after initial injury. Based on |
|
|
|
the available evidence, surgical decompression of the |
|
|
|
optic canal is not routinely recommended. If treatment |
|
|
|
with either steroids, surgical intervention or both is |
|
|
|
considered, appropriate information and informed |
|
|
|
consent should be given to the patient and their family; |
|
|
|
they should know (and sign) the potential benefits and |
|
|
|
the risks. |
|
|
|
CHORIORETINITIS SCLOPETARIA |
|
|
|
Definition |
|
|
|
It is a proliferation of fibrous tissue in the choroid and |
Fig. 31.9: Retinitis sclopetaria |
|
|
retina as the result of contusion of the sclera by a high |
|
||
|
|
|
|
198 |
|
Clinical Diagnosis and Management of Ocular Trauma |
|
|
The role of steroids is also in debate with no demons- |
|
|
|
|
|
|
|
|
tration of real benefit in their application. |
|
|
|
PURTSCHER RETINOPATHY |
|
|
|
Definition and Causes |
|
|
|
Purtscher retinopathy is a hemorrhagic and vaso- |
|
|
|
occlusive vasculopathy, which, in 1912, was first |
|
|
|
||
|
|
described as a syndrome of sudden blindness associated |
|
|
|
with severe head trauma. These patients had findings |
|
|
|
of multiple white retinal patches and retinal hemor- |
|
|
|
rhages that were associated with severe vision loss. |
|
|
|
Since its original description, Purtscher retinopathy has |
|
|
|
been associated with traumatic injury, primarily blunt |
|
|
|
thoracic trauma and head trauma, but also with |
Fig. 31.10: Purtscher retinopathy |
|
|
numerous non-traumatic diseases; it is seen in diverse |
|
|
|
conditions, including acute pancreatitis, fat emboli- |
include serous detachment of the macula, preretinal |
|
|
zation, amniotic fluid embolization, and vasculitic |
|
|
|
hemorrhages, dilated vessels, and optic disc edema. |
|
|
|
diseases. Bilateral manifestations are seen most |
|
|
|
Confluent cotton-wool spots in the central macula may |
|
|
|
commonly in systemic conditions, but unilateral |
|
|
|
simulate the cherry-red spot that is seen in central retinal |
|
|
|
findings have been also reported. Decreased vision |
|
|
|
artery occlusion. Retinal microinfarcts that are observed |
|
|
|
occurs in the affected eyes, generally in the range of |
|
|
|
in patients with fat embolization are usually smaller |
|
|
|
20/200 to counting fingers. Vision can often improve |
|
|
|
in size and located in the peripheral, not central, retina. |
|
|
|
within several months to a range of 20/30 to 20/200, |
|
|
|
Pigment migration and optic atrophy have been |
|
|
|
depending on the severity of the retinal findings. |
|
|
|
reported as late findings in the disease (Fig. 31.10). |
|
|
|
|
|
|
|
Hystopathology |
Angiogram with fluoresceine is very useful to |
|
|
corroborate the ischemic damage, but many times the |
|
|
|
The exact pathophysiology remains somewhat |
|
|
|
only characteristic clinical pattern, is enough to |
|
|
|
controversial, and different mechanisms have been |
determine the diagnosis. Without history of trauma, |
|
|
described; the main mechanism purposed is vascular |
physician should consider fat embolization, amniotic |
|
|
occlusion. The characteristic white lesions are known |
fluid embolization, retinal vasculitis, system lupus |
|
|
as cotton-wool spots, and correspond to retinal |
|
|
|
erythematosus, dermatomyositis, scleroderma and |
|
|
|
microinfarcts at the level of the nerve fiber layer, caused |
|
|
|
radiation retinopathy, between others. |
|
|
|
by the ischemic lesion. Fluorescein angiogram reveals |
|
|
|
|
|
|
|
leakage, and it can suggests that an acute endothelial |
Management |
|
|
cell injury is caused by trauma; possibly this is the |
|
|
|
No proven treatment exists for Purtscher retinopathy |
|
|
|
predisposing factor that lead the retinal vessels to |
|
|
|
occlusion. Other possible sources of emboli include |
that occurs after traumatic injury. In patients with |
|
|
fat emboli in cases of long bone fractures and perhaps |
retinopathy due to systemic vasculitis, steroid therapy |
|
|
pancreatitis from enzymatic digestion of omental fat, |
is theoretically beneficial. |
|
|
amniotic fluid embolization during childbirth and post- |
Visual prognosis is guarded, although initially |
|
|
partum, air emboli from traumatic chest compression, |
decreased vision may improve over a period of months. |
|
|
and granulocyte aggregation resulting from |
The most important prognostic finding that is associated |
|
|
complement activation. |
with a poor visual prognosis is central macular |
|
|
|
infarction, due to the ischemic condition. |
|
|
Diagnosis |
|
In a funduscopic view, macular cotton-wool spots and intraretinal hemorrhages in patients with this history of trauma are diagnostic of the condition. Patients with traumatic Purtscher retinopathy present with a recent history of blunt chest trauma or head trauma. The severity of chest trauma is not always correlated with the incidence and/or severity of retinopathy, which is observed in these patients. Some other findings can
Bibliography
1.Abrams GW, Topping TM, Machemer R. Vitrectomy for injury: The effect on intraocular proliferation following perforation of the posterior segment of the rabbit eye.
Arch Ophthalmol 1979;97:743.
2 Alapatt J, Hutchins R. Retinal detachments due to traumatic tears in the pars plana ciliaris. Retina 1998;18:506.
|
Management of Blunt Retinal Trauma |
|
|
199 |
||
3. |
Barr CC. Prognosis factors in corneoscleral lacerations. |
19. |
Gass JDM. Stereoscopic Atlas of Macular Disease: |
|
||
|
Arch Ophthalmol 1994;101:919. |
|
Diagnosis and Treatment. ed 3. St. Louis: CV Mosby |
|
||
4. |
Barr CC, Vine AK, Martonyi CL. Unexplained hetero- |
|
1987. |
|
|
|
|
chromia. Intraocular foreign body demonstrated by |
20. |
Goffstein R, Burton TC. Differentiating traumatic from |
|
||
|
computed tomography. Surv Ophthalmol. 1984;28:409. |
|
nontraumatic retinal detachment. Ophthalmology |
|
||
5. |
Berlin R. Zur sogenannten commotio retinae. Klin |
|
1982;89:361. |
|
|
|
|
Monatsbl Augenheilkd 1873;11:42. |
21. |
Hart JCD, Frank HJ. Retinal opacification after blunt |
|
||
6. |
Blight R, Hart JCD. Structural changes in the outer |
|
nonperforating concussional injuries to the globe: A |
|
||
|
retinal layers following blunt mechanical nonperforating |
|
clinical and retinal fluorescein angiographic study. Trans |
|
||
|
|
|
||||
|
trauma to the globe: An experimental study. Br J |
|
Ophthalmol Soc UK. 1975;95:94. |
|
||
|
Ophthalmol Soc UK. 1978;98:270. |
22. |
Hilton GF. Late serosanguineous detachment of the |
|
||
7. |
Brinton CS, Topping TM, Hyndiuk RA, et al. Post- |
|
macula after traumatic choroidal rupture. Am J |
|
||
|
traumatic endophthalmitis. Arch Ophthalmol 1984; |
|
Ophthalmol 1975;79:997. |
|
|
|
|
102:547. |
23. |
Kaufer G, Zimmerman IE. Direct rupture of choroid. |
|
||
8. |
Chang S. Low viscosity liquid fluorochemicals in |
|
Arch Ophthalmol 1966;75:384. |
|
||
|
vitreous surgery. Am J Ophthalmol 1987;103:38. |
24. |
Kohno T, Ishibashi T, Inomata H, et al. Experimental |
|
||
9. |
Chang S, Reppucci V, Zimmerman NJ, et al. Perfluoro- |
|
macular edema of commotio retinae: Preliminary report. |
|
||
|
carbon liquids in the management of traumatic retinal |
|
Jpn J Ophthalmol 1983;27:149. MEDLINE |
|
||
|
detachments. Ophthalmology 1989;96:785. |
25. |
Lewis H, Blumenkranz M, Chang S. Treatment of |
|
||
10. |
Cogan DG. Pseudoretinitis pigmentosa: Report of two |
|
dislocated crystalline lens and retinal detachment with |
|
||
|
traumatic cases of recent origin. Arch Ophthalmol |
|
perfluorocarbon liquids. Retina 1992;12:299. |
|
||
|
1969;81:45. |
26. |
Martin DF, Awh CC, McCuen BW, et al. Treatment and |
|
||
11. |
Coleman DJ. Early vitrectomy in the management of the |
|
pathogenesis of traumatic chorioretinal rupture |
|
||
|
severely traumatized eye. Am J Ophthalmol 1982; |
|
(Sclopetaria). Am J Ophthalmol 1994;117:190. |
|
||
|
193:543. |
27. |
Noyes HD. Detachment of the retina, with laceration of |
|
||
12. |
Cox MS, Schepens CL, Freeman HM. Retinal detach- |
|
the macula lutea. Trans Am Ophthalmol Soc 1871;1:128. |
|
||
|
ment due to ocular contusion. Arch Ophthalmol |
|
MEDLINE. |
|
|
|
|
1966;78:678. |
28. |
Ross WH. Traumatic retinal dialyses. Arch Ophthalmol |
|
||
13. |
Crouch ER, Apple DJ. Post-traumatic migration of retinal |
|
1981;99:1371. |
|
|
|
|
pigment epithelial melanin. Am J Ophthalmol |
29. |
Rubsamen PE, Cousins SW, Winward KE, et al. |
|
||
|
1974;78:251. |
|
Diagnostic ultrasound and pars plana vitrectomy in |
|
||
14. deJuan E, Sternberg P, Michels RG, et al. Penetrating |
|
penetrating ocular trauma. Ophthalmology 1994; |
|
|||
|
ocular injuries: Types of injuries and visual results. |
|
101:809. |
|
|
|
|
Ophthalmol 1983;90:1318. |
30. |
Smith RE, Kelley JS, Harbin TS. Late macular |
|
||
15. |
Delori F, Pomerantzeff O, Cox MS. Deformation of the |
|
complications of choroidal ruptures. Am J Ophthamol |
|
||
|
globe under high-speed impact: Its relation to contusion |
|
1974;77:650. |
|
|
|
|
injuries. Invest Ophthalmol 1969;8:290. |
31. |
Thompson JT. Traumatic retinal tears and detachments. |
|
||
16. |
Dumas JJ. Retinal detachment following contusion to the |
|
In: Shingleton BJ, Hersh PS, |
Kenyon KR editor. Eye |
|
|
|
eye. Int Ophthalmol. 1967;7:19. |
|
Trauma. St Louis: Mosby–Year Book 1991;195. |
|
||
17. |
Eliott D, Avery RL. Nonpenetrating posterior segment |
32. |
Weidenthal DT, Schepens CL. Peripheral fundus |
|
||
|
trauma. Ophthalmol Clin North Am 1995;8:647. |
|
changes associated with ocular contusion. Am J |
|
||
18. |
Fuller B, Gitter KA. Traumatic choroidal rupture with late |
|
Ophthalmol. 1966;62:465. |
|
|
|
|
serous detachment of macula: Report of successful argon |
33. Zion VM, Burton TC. Retinal dialysis. Arch Ophthalmol. |
|
|||
|
laser treatment. Arch Ophthalmol 1973;89:354. |
|
1980;98:1971. |
|
|
|
|
|
|
|
|
|
|
C H A P T E R
32Applications of Stem Cell
Therapy in Ophthalmology
Rajpal Vohra (India)
Introduction
In Ophthalmology, there are various conditions where there is no treatment available like Retinal degenerations, and total deficiency of stem cells which occurs in alkali burns in cornea. Stem cells are recent advances in Ophthalmology, which has given newer therapeutic modalities in the management of retinal diseases, which were thought to be incurable. Stem cell therapy is an upcoming new mode of treatment in present time. Stem cell research offers hope to countless patients whose conditions have here to fore been deemed incurable. Better understanding of stem cell behaviors and functions will lead to insights into biological mysteries encompassing the fields of angiogenesis, development, tissue homeostasis, wound healing, and carcinogenesis.
The potential use of stem cells in the treatment of a variety of human retinal disease remains tremendously exciting. There is by ethical controversy in use of fetal tissue so the actual potential use of such approaches remains yet unexplored. Adult tissue is less controversial and more readily available, holds promise but the pluripotency and actual utility of stem cells obtained from this source remains uncertain. Clearly, populations of progenitor cells exist in the ciliary margin and bone marrow and each may have significant utility as we seek to repair and rebuild damaged retinas. Even if such complex tissue reconstruction could be successfully completed, re-establishing functional visual pathways will be an even greater challenge.
Definition of Stem Cells
Stem cells are pluripotent cells capable of differentiating into variety of cell types. There are two sources of stem cells:
1.Stem cells from adult tissue
2.Stem cells from fetal material – called embryonic stem cells.
Embryonic stem cells are typically isolated from blastocysts and have pluripotency.they can give rise to virtually any adult tissue cell type under appropriate conditions. Truly pluripotent embryonic stem cells have been identified that can give rise to a multitude of differentiated cell types. Stem cell is the origin of life. Ultimate the stem cell, fertilized egg, is formed from fusion of the haplid progeny of germinal stem cells.The fertilized egg is totipotent.
Adult derived stem cells typically reside in adult tissue in a quiescent, undifferentiated state and under appropriate stimuli will divide and differentiate into the cell types of tissue in which they reside or if appropriately stimulated into other cell types. Normal tissue renewal is accomplished by the differentiating progeny of the stem cells, the so called transitamplifying cells.
During early embryonic development, each cell divides and gives rise to two daughter cells with the same potential:symmetric division. During normal tissue renewal in the adult, each progenitor cell gives rise to one daugther cell that remains a progenitor cell, and one daugther cell that begins the process of determination to a terminally differentiated cell leading to terminationasymmetric division. During normal tissue renewal in adult organs, tissue stem cells give rise to progeny that differentiated into mature functioning cells of that tissue. Stem cell with less than totipotentiality are called Progenitor Cells.
The Ivanova et al are doing large scale genomic analysis and Ramalho– Santos M et al are doing transcriptional profiling of stem cells.
At present there is a controversy whether adult tissue containing pluripotent stem cells will serve as a source of regenerative tissue.
Lee MS et al, has done recent clinical trial using adult bone marrow (BM) derived stem cells to regenerate infracted myocardium have reported success in improving cardiac functions. Presuming on the basis of bone marrow stem cells differentiating into
|
Applications of Stem Cell Therapy in Ophthalmology |
|
201 |
|
myocardium is not supported by experimental data |
mammal does not show regenerative capacity after |
|
||
by Murry CE et al. According to Balasam LB et al |
damage, there is a possibility for the reinitiation of stem |
|
||
hematopoietic stem cells adopt mature hematopoietc |
cell potential at the peripheral retinal margin, from |
|
||
fates in ischemic myocardium. According to Anderson |
the RPE or from the Muller glial cells. The application |
|
||
DJ, et al these clinical observations cannot be |
of information derived from the studies of retinal |
|
||
invalidated but raises many questions regarding |
progenitor cells in developing organisms should soon |
|
||
interpretation and emphasizes that there is a need to |
provide a test of these possibilities. |
|
||
establish rigorous standards by which such clinical |
This regenerative capacity derives from quiescent |
|
||
|
||||
studies are evaluated. |
stem cells that reside in the adult retina of these species. |
|
||
|
Very limited work has been done regarding retinal |
Similar regenerative capacity has been demonstrated |
|
|
stem cells.There has been extensive literature work |
in mammalian retina. For a population of retinal stem |
|
||
done an stem cells giving rise to vascular, muscle |
cells to exist in the adult retina, it would have been |
|
||
nervous hemopoietic tissue. Very limited work has |
necessary for such a population of progenitor cells to |
|
||
been done on the retinal stem cells. |
remain quiescent after the retina has fully differentiated. |
|
||
|
There are four basic population of cells that may |
Livesey FJ et al has done large scale Genomic anlysis. |
|
|
contain dormant progenitor cells. |
Blackshaw S et al has done Genomic analysis of mouse |
|
||
1. Retinal stem cells that can give rise to |
retinal development. |
|
||
|
photoreceptors |
The work of livesey and Blackshaw can serve as |
|
|
2. |
Muller/glial stem cells |
the starting point for the evaluation of numerous genes |
|
|
3. |
Retinal pigment epithelial [RPE]; and endothelial |
and their potential role in the regulation of retinal cell |
|
|
|
progenitor cells [EPC] |
developmental determination. How genes are |
|
|
|
Recently adult bone marrow-derived HSCs |
progressively switched on and off in an orderly fashion |
|
|
containing EPC is an intresting areas of research. |
during the generation of specific retinal cell types, and |
|
||
|
|
how this overlaps with gene sets utilized during the |
|
|
Role of Retinal Stem Cells and |
establishment of other, nonretinal neuronal cell types, |
|
||
will contribute significantly to our understanding of |
|
|||
Muller Glial Cells |
retinal progenitor biology. Dyer MA et al has done |
|
||
study in regulation of cell proliferation in retinal |
|
|||
Reh TA et al. has shown that regenerative capacity |
development. Das AV et al has done identification of |
|
||
exists in retina of amphibians and chicken embryos |
c-KIT receptor as a regulator of adult neural stem cells |
|
||
after injury.The vertebrate retina is derived from paired |
in the mammalian eye and the role of various |
|
||
evaginations from the neural tube in embryonic |
transcription factor and signaling molecules during this |
|
||
development and is initially produced by progenitor |
process have provided insight into putative |
|
||
cells similar to those that generate the neurons and |
mechanisms whereby the mammalian retina holds in |
|
||
glia of other areas of the central nervous system. In |
reserve a subset of progenitor cells that theoretically |
|
||
some amphibians and fish, the retina continues to grow |
could be used to regenerate damaged issued in the |
|
||
along with the eye throughout the life of the animal. |
in the adult. Clearly, James J et al has studied the the |
|
||
The new retinal cells are added at the ciliary margin |
development state of the retina and the context in |
|
||
of the eye from the mitotic activity of neural/glial stem |
which a specific cell finds itself will determine how a |
|
||
cells in a region known as the germinal zone and are |
particular retinal progenitor cell behaves: whether it |
|
||
seamlessly incorporated into the existing retinal circuitry. |
will terminally differentiate or maintain a quiescent state |
|
||
Little is known about the cell or molecular biology of |
from which it can letter emerge to give rise to cells |
|
||
these stem cells; however, studies of retinal progenitor |
useful in repair of a damaged retina will depend not |
|
||
cells in chick and mammalian embryos have led to |
only on its own developmental programme, but the |
|
||
the identification of several factors that control their |
microenmorvironment in which it finds it self. |
|
||
proliferation. Moreover, studies of retinal regeneration |
James J et al has done cellular and molecular |
|
||
have shown that retinal stem cells can also be derived |
characterization of early and late retinal stem cells/ |
|
||
from two or perhaps three additional sources after |
progenitors: differential regulation of proliferation and |
|
||
retinal damage: (a) the retinal pigmented epithelium |
context dependent roll of notch signaling. |
|
||
(RPE) in amphibians and embryonic chicks and |
James J et al has done transcriptional profiling |
|
||
mammals; (b) a specialized rod progenitor in fish; and |
studies of retina at different states of development |
|
||
(c) the Muller glial cells. While there is currently no |
coupled with in vitro studies of progenitor cell |
|
||
evidence for a neural/glial stem cell in the adult |
populations should provide the information necessary |
|
||
mammalian retina, and the retina of the mature |
to begin such an analysis and determine what |
|
||
|
|
|
|
|
202 |
|
Clinical Diagnosis and Management of Ocular Trauma |
|
|
conditions help maintain quiescence and what |
activation of intrinsic genes. These studies are most |
|
|
|
||
|
|
conditions stimulate proliferation and subsequent |
provocative, could provide additional insight into |
|
|
differentiation of retinal progenitor cell populations. |
retinal regeneration in mammals, and provide a |
|
|
Konobu T et al have shown that cells with |
rationale for the targeting of Muller glial in certain |
|
|
characteristics of retinal neuron have been obtained |
inherited and acquired retinal degenerative disorders. |
|
|
from a number of embryonic tumor cell line, including |
If we isolate retinal stem cells from the adult |
|
|
neuroblastoma, gliaoblastoma, but because of the |
mammalian eye and then using them to regenerate |
|
|
malignant potential of these cells they are not likely |
diseased retina then it will have a great therapeutic |
|
|||
|
|
to be useful. |
effect. There have been some reports suggesting that |
|
|
Martinez-Serrano A et al, have cultured virally |
if multipotent progenitor cells isolated from retina of |
|
|
transformed, immortalized neuronal precursors were |
neonatal mice retina are used in the early, then some |
|
|
evaluated for their ability to differentiate into retinal |
level of visual function may be obtained in animal eyes |
|
|
neurons after intraocular implantation. |
with retinal degeneration. At cellular level it is very |
|
|
Bain G et al have attempted at inducing in vitro |
difficult to establish functional neuronal connection |
|
|
differentiation of embryonic stem cells into retinal |
between implanted progenitor cells or sheets of |
|
|
neuronal phenotypes were done using a variety of |
photoreceptor and the host’s nerve fiber layer prior |
|
|
factors, including retinoic acid. |
to reestablishing visual pathways that would lead to |
|
|
Tropepe V, et al has identified Retinal progenitor |
functional vision. |
|
|
stem cells in the adult mammalian eye. Ahmad I, et al |
|
|
|
have done Identification of neural progenitors in the |
Role of Retinal Pigment |
|
|
adult mammalian eye. Retinal progenitor cells have |
|
|
|
been identified in ciliay margin. These cells were not |
Epithelial Stem Cells |
|
|
isolated from central or peripheral pigmented |
|
|
|
epithelium. These cells are clonally expanded in culture |
RPE cells and photoreceptors enjoy an close |
|
|
to give rise to a variety of retinal cells types, including |
relationship both anatomically and functionally. Where |
|
|
rod photoreceptors, bipolar neurons, and muller glia. |
is the principal underlying defect in many inherited |
|
|
The differentiation of these cells from the ciliary margin |
retinal degenerations is still a question: the |
|
|
pigmented cell progenitors is not due to |
photoreceptor or RPE cells ?. Although with the advent |
|
|
transdifferentiation of the ciliary margin cells, but rather, |
of molecular genetics this confusion has become less, |
|
|
clonal proliferation and defferentiation as observed in |
but the interdependency between these two cells types |
|
|
a true stem cell. |
remains and there is often concomitant degeneration |
|
|
Fischer AJ et al have shown that in chicken an adult |
of both cell types observed in a variety of inherited |
|
|
differentiated muller gila can serve as a source of stem |
and acquired degenerative disease of the retina. In |
|
|
cells that will, in response to injury, or cytokinenes, |
this regard—RPE cell transplantation has been |
|
|
differentiate, proliferate and redifferentiate into |
evaluated both for its potential to replace diseased RPE |
|
|
additional glial cells or neurons. |
as well as to provide a source of cells whose phenotypic |
|
|
Turner DL, et al have identified common progenitor |
differentiation may be manipulated by various |
|
|
cells that gives rise to both Muller glia and retinal |
cytokines and trophic substances. Thus, RPE cell lines |
|
|
neurons. |
have been developed for use as RPE cell transplants, |
|
|
Thus, the concept that Muller glia of the adult retina |
cell-based drug delivery platforms, and “photoreceptor |
|
|
can serve as potential source of retinal stem cells is |
stem cells”. |
|
|
consistent with molecular profiling of developing |
Transplantable RPE cell lines may serve as stem |
|
|
mammalian retinas that shown a high degree of |
cells of sorts to replenish diseased RPE cells themselves. |
|
|
similarity between the gene expression profiles of Muller |
In a number of macular and retinal degenerative |
|
|
glia and mitotic retinal progenitor cells in the mouse. |
disorders there is atrophy of the RPE and associated |
|
|
Since the Muller glia are the cells that commonly |
malfunctioning in the phototransducing cellular |
|
|
proliferate in response to retinal injury, it would not |
machinery. Damaged RPE cells and associated atrophy |
|
|
be surprising that these cells also retain the potential |
are hallmarks of age-related macular degeneration and |
|
|
to defferentiate along a number of pathways, some |
heroic surgical approaches have been considered to |
|
|
of which may lead to retinal neuronal replacement. |
provide photoreceptors in such individuals with |
|
|
Ooto S et al have done a recent study significantly |
healthier, RPE-rich regions of the retina through retinal |
|
|
expanded this concept: amarcine, horizontal, and |
translocation and the insertion of RPE sheets. |
|
|
photoreceptor phenotypes were mammalian retina in |
Human RPE cell lines enjoy an extended life span |
|
|
the presence of extrinsic factors (e.g. retinoic acid) or |
after being stably transfected with a plasmid encoding |
|
|
|
|
Applications of Stem Cell Therapy in Ophthalmology |
|
203 |
|
the simian virus 40 large T antigen and many of the |
circumstances, provide a transplantable pool of cells |
|
|
factors expressed by functional RPE cells in vivo are |
to rescue diseased photoreceptors and, as such, have |
|
|
observed to be expressed by these transformed cell |
utility in the treatment of retinal degenerations. |
|
|
lines. When these cells are transplanted subretinally |
|
|
|
into a rat model of retinal degeneration (the RCS rat), |
Role of Bone Marrow: Derived |
|
|
loss of visual function is attenuated and cortically |
|
||
dependent visual function is preserved long-term. |
Stem Cells |
|
|
These RPE cell lines can be transferred with plasmids |
|
|
|
|
|||
encoding a variety of trophic factors shown to have |
BONE MARROW HEMATOPOIETIC |
|
|
protective effects on photoreceptors and then |
|
||
STEM CELLS |
|
||
encapsulated into polymer devices that permit diffusion |
|
||
In 1917, Pappenhein postulated the existensce of an |
|
||
of cell products into the tissue into which they are |
|
||
undifferentiated stem cell for blood cells. The hema- |
|
||
transplanted. When transformed RPE cell lines are |
|
||
topoietic or blood forming cells are located in the bone |
|
||
transfected with a plasmid encoding one such factor, |
|
||
marrow. The lineage of blood cells extends from a |
|
||
ciliary neurotrophic factor (CNTF), and transplanted |
|
||
resting stem cell, to transitamplifyilng precursor cells, |
|
||
directly into the vitreous of dogs with retinal |
|
||
to mature circulting blood cells. Untill recently, most |
|
||
degeneration, photoreceptor degeneration is reduced. |
|
||
primitive bone marrow progenitor cell was believed |
|
||
Further more, production of this factor and |
|
||
to be pluripotent, giving rise to stromal cells and |
|
||
implantation of the encapsulation device into the |
|
||
lymphocytic cells, as well as RBCs, WBCs. In addition |
|
||
vitreous of normal rabbits did not lead to toxic effects |
to hematopoietic precursor, bone marrow also |
|
|
on either the electroretinogram or retinal histology in |
contains a mesenchyamal progenitor cell can give rise |
|
|
these animals at doses that protect photoreceptors in |
to many other cell types such as muscle cells, astrocytes, |
|
|
dogs with retinal degeneration. Such cell-based |
and neurons,as well as stromal cells that support |
|
|
delivery devices may be used to provide trophic factors |
hematopoiesis. However, the accumulating evidence |
|
|
for the treatment of a variety of retinal degenerative |
is that, not only does the bone marrow contain a pluri/ |
|
|
diseases and, in fact have recently been used in a |
multipotent blood forming stem cell, but it also contains |
|
|
human clinical trial evaluating the efficacy of CNTF |
a cell that has the capacity to circulate to other organs |
|
|
in the treatment of retinal degeneration. In this respect, |
and replace different nonhematopoietic tissues. |
|
|
the implanted encapsulated cell devices function as a |
Although these bone marrow-derived cells have |
|
|
stem cell, providing factors critical to the prevention |
markers of the hematopoietic stem cell [HSC], it has |
|
|
of, or recovery from, retinal degenerative disease. |
not been ruled out that this multipotent cell may be |
|
|
Spontaneously differentiating human embryonic |
of stromal origin. Serial transplantation indicates that |
|
|
stem cell lines having many molecular and functional |
a single bone marrow cell may give rise to many |
|
|
characteristics of RPE cells have been touted as a |
different tissue types and suggest that a common |
|
|
potential source of transplantable RPE cells for |
precursor must exist, not only for stromal and |
|
|
hematopoietic lineages, but also other germ layer- |
|
||
subretinal transplantation into human retinas. Large- |
|
||
derived cell types. It is this putative totipotent bone |
|
||
scale genomic analysis was used to compare these cells |
|
||
marrow cell that has stimulated the great revival of |
|
||
to primary human RPE cell lines and they were found |
|
||
interest in adult stem cells in the last few years. There |
|
||
to resemble more closely the molecular signature of |
|
||
are still some caveats to the generally accepted |
|
||
primary RPE cells than previously reported, established |
|
||
assumption of pluripotentiality of tissue stem cells |
|
||
human RPE cell lines. If these cell lines can be |
|
||
including HSCs. |
|
||
maintained in cell banks and altered so as to facilitate |
|
||
|
|
|
|
immune acceptance, they may represent a source of |
|
|
|
transplantable tissue. |
Role of Adult Bone Marrow: |
|
|
Studies done over a decade ago evaluated the |
|
||
potential use of RPE cells as stem cells of sorts: when |
Derived Endothelial Progenitor |
|
|
RPE cells were injected subretinally into the eyes of |
(Stem) Cells |
|
|
mice with inherited retinal degeneration, rescue of |
|
|
|
photoreceptors was observed. It was found that |
Abnormalities in the retinal or choroidal vasculature: |
|
|
exogenously injected basic fibroblast growth factor |
macular edema, retinal and vitreous hemorrhage, and |
|
|
could mimic this rescue. This led to the concept that |
fibrovascular scarring commonly contribute to visual |
|
|
RPE cells may, under appropriate conditions, serve |
loss in diseases such as age retinal macular degene- |
|
|
as a form of cell-based therapy and may, under certain |
ration, diabetic retinopathy, retinopathy of prematurity, |
|
|
|
|
|
|
204 |
|
Clinical Diagnosis and Management of Ocular Trauma |
|
|
and neovascular glaucoma. Retinitis pigmentosa are |
anywhere but in or near blood vessels since these cells |
|
|
|
||
|
|
commonly thought of as neuronal degenerations, but |
are derived from green fluorescent protein. How this |
|
|
most also exhibit vascular abnormalities traditionally |
is going to be used in human is still in question? |
|
|
attributed to loss of neuronal elements and accompan- |
|
|
|
ying decreased metabolic demand leading to vascular |
Role of Bone Marrow: Derived |
|
|
atrophy. Otoni A et al have describe a newly emerging |
|
|
|
paradigms: the existence of trophic “cross-talk” |
Stem Cells in Retinal and |
|
|
between local vascular networks and the tissues they |
Choroidal Neovascularization |
|
|
supply and such interactions almost certainly help to |
|
|
|
maintain a functional differentiated state in a variety |
It was Grant and colleague who has first directly |
|
|
of organ systems. Shen Q et al have shown that, |
demonstrated that systemically administered HSC |
|
|
endothelial cells are also now known to provide trophic |
(Hematic stem cell can function as Hemangioblast |
|
|
substance that greatly stimulate self-renewal and |
during hypoxia stimulated retinal neovascularization). |
|
|
expand neural differentiation of neural stem cells.Given |
Hematopoetic stem cells contains a pool of EPCs |
|
|
such interdependency of vascular endothelial cells and |
(endothelial progenitor cells) capable of incorporating |
|
|
surrounding tissues, it may be possible to use one cell |
into retinal vasculature has recently been demonstrated |
|
|
type to rescue the other in the face of severe stress |
by several groups. Grant and colleague have |
|
|
such as hypoxia or genetically encoded cell-specific |
demonstrated that circulating, undifferentiated |
|
|
degenerations. Under such conditions it would be |
precursor cells can be recruited to sites of retinal |
|
|
desirable to have available populations of progenitor |
neovascularization and, along with proliferation of local |
|
|
cells useful for such protection. |
endothelial cells, can contribute to new blood vessel |
|
|
BONE MARROW: DERIVED STEM CELLS |
growth and development. The relative contribution |
|
|
of circulating precursor cells and endogenous retinal |
|
|
|
CAN EXERT A NEUROTROPHIC RESCUE IN |
vascular endothelial cells to newly forming vasculature |
|
|
RETINAL DEGENERATION |
in human disease remains unknown; the experiments |
|
|
Humphries P et al has done molecular genetics of |
of Grant and colleagues demonstrate that circulating |
|
|
retinitis pigmentos and has identified mutations in over |
cells can incorporate into laser-stimulated retinal |
|
|
110 different genes, accounting for only a relatively |
neovascularization, but the role of these cells in |
|
|
small percentage of the known affected individuals |
nonirradiated hosts where the proliferation of local |
|
|
many of these mutations are associated with enzymatic |
inflammatory, precursor, and endothelial cells is not |
|
|
and structural components of the phototransduction |
impaired by lethal irradiation remains unclear. Studies |
|
|
machinery, including rhodopsin. Most inherited human |
from several groups have demonstrated, using the |
|
|
retinal digenerations |
same irradiation/bone marrow reconstitution model |
|
|
Otoni A et al have shown that bone marrow – |
that circulating stem cells can also contribute to laser- |
|
|
derived stem cells exert vasculotrophic properties. |
stimulated choroidal neovascularization. |
|
|
These cells have also recently been reported to |
Dorrell MI, et al have demonstrated a role for the |
|
|
completely prevent retinal vascular degeneration |
adhesion molecule, R-Cadherin, in the targeting of |
|
|
ordinarily observed in mouse models of retinal |
HSC to the retinal vasculature when small molecule |
|
|
degeneration, and the vascular rescue correlates with |
antagonizes or function blocking antibodies to |
|
|
neuronal rescue. The inner nuclear layer remains nearly |
R-Cadherin are used to pretreat Lin-HSC prior to |
|
|
normal and the outer nuclear layer containing |
intravitreal injection, the cells no longer target sites of |
|
|
photoreceptors is significantly preserved, with the |
angiogensis and participate in the formation of new |
|
|
rescued mice being predominantly cones. Detectable, |
retinal blood vessels. Integrin alpha 4 beta 1, a |
|
|
albeit severely abnormal electroretinogram recordings |
adhesion molecules may play a role in targeting |
|
|
are observed in rescued mice at time when they are |
circulating EPCs to sites of abnormal angiogenesis |
|
|
never observed in control treated, or untreated, rd/ |
during vascularization of tumor, and that these integrin |
|
|
rd eyes. This rescue effect is also observed when human |
may be potential therapeutic target if, indeed circulating |
|
|
bone marrow-derived LinHSCs are used to treat |
EPCs contribute to pathological ocular angiogenesis. |
|
|
severe combined imnunodeficient mice with retinal |
Interfering with the function of such targeting molecule |
|
|
degeneration. Large-scale genomic analysis of rescued |
used by EPCs to target sites of pathological |
|
|
eyes revealed significant upregulation of antiapoptotic |
neovascularization in combination with cell based |
|
|
gene. It is important to note that the injected bone |
therapies to produce angiostatic molecues locally could |
|
|
marow-derived progenitor cells are never observed |
significantly reduced abnormal angiogenesis. |
|
|
|
|
Applications of Stem Cell Therapy in Ophthalmology |
|
205 |
|
BONE MARROW—DERIVED STEM CELLS CAN |
derived cells, placenta-derived cells, and mesenchymal |
|
|
EXERT A VASCULOTROPHIC RESCUE EFFECT |
stem cells were studied; dermal fibroblasts served as |
|
|
Otoni A at al have injected LinHSCs directly into |
cell controls. At various ages up to 100 days, |
|
|
electroretinogram responses, spatial acuity and |
|
||
the eyes of newborn mice while they were forming |
|
||
luminance threshold were measured. Both umbilical- |
|
||
their retinal vasculature; in this environment, these cells |
|
||
derived and mesenchymal cells significantly reduced |
|
||
can target activated astrocytes, a hallmark of many |
|
||
the degree of functional deterioration in each test. The |
|
||
ocular vascular and degenerative diseases. Once |
|
||
effect of placental cells was little better than controls. |
|
||
targeted to this template of activated astrocytes, the |
|
||
Umbilical tissue-derived cells gave large areas of |
|
||
Lin HsCs participate in normal developmental |
|
||
photoreceptor rescue; mesenchymal stem cells gave |
|
||
angiogenesis in both neonatal mice or injury-induced |
|
||
neovascularization in the adult. |
only localized rescue. Fibroblasts gave sham levels of |
|
|
The HSC fraction used in these studies not only |
rescue. Donor cells were confined to the subretinal |
|
|
inhibited angiogenesis when engineered to express an |
space. There was no evidence of cell differentiation |
|
|
antiangiogenic, but also resued and stabilized |
into neurons, of tumor formation or other untoward |
|
|
(e.g. matured) degenerating vessels. More surprisingly, |
pathology. Since the umbilical tissue-derived cells |
|
|
it was also observed that by preventing vascular |
demonstrated the best photoreceptor rescue and |
|
|
degenertion there is a trophic rescue effect on the |
unlike mesenchymal stem cells were capable of |
|
|
photoreceptors themselves, suggesting that autologuous |
sustained population doublings without karyotypic |
|
|
bone marrow grafts of HSC fractions containing EPC |
changes, it is proposed that they may provide utility |
|
|
may provide trophic effects on associated neural tissue |
as a cell source for the treatment of retinal degenerative |
|
|
that goes beyond simple nutrition. Such observations |
diseases such as retinitis pigmentosa. |
|
|
could provide a rationale for the use of HSC in the |
|
|
|
treatment of a variety of inherited retinal degenerations |
Recent Advances |
|
|
such as retinitis pigmentosa. |
|
||
The use of stem cells are difficult and it is also very |
|
|
|
Atmaca-Sonmez P et al have investigated whether |
|
||
difficult to transfer and, it will be necessary to improve |
|
||
hematopoietic stem cells (HSC) given systemically can |
|
||
transfection efficiency. The use of human stem cell for |
|
||
home to the damaged subretinal space and express |
|
||
cell base therapy in the eye present a technical |
|
||
markers of RPE lineage. They have shown that |
|
||
challenge. |
|
||
systemically injected HSC homed to the subretinal |
|
||
Another enigma in the circulating stem cell filled |
|
||
space in the presence of RPE damage and that FC |
|
||
is the issue of HSC “Homing”, R-Cadherin is clearly |
|
||
promoted survival of these cells. Furthermore, the RPE- |
|
||
involved, but all of the molecular signals have not yet |
|
||
specific marker RPE-65 was expressed on adoptively |
|
||
been identified. Identification of these signals would |
|
||
transferred HSC in the denuded areas. |
|
||
be of immense benefit in terms of exploiting the |
|
||
Harris JR et al have shown that HSCs/HPCs can |
|
||
potential use of HSC in therapeutic angiogenesis as |
|
||
migrate to the RPE layer after physical or chemical |
|
||
well as directed cell therapy. Finally, which shall type |
|
||
injury and regenerate a portion of the damaged cell |
|
||
in adult bone marrow actually adheres to astrocytes |
|
||
layer. Bone marrow-derived cells home to and |
|
||
and incorporate into the developing vasculature. |
|
||
regenerate retinal pigment epithelium after injury. |
|
||
Lund RD et al have shown cells isolated from |
|
||
The wet form of ARMD is characterized by |
|
||
umbilical cord tissue rescue photoreceptors and visual |
|
||
choroidal neovascularization (CNV). A prior study has |
|
||
functions in a rodent model of retinal disease. |
|
||
shown that adult hematopoietic stem cells (HSCs) |
|
||
Progressive photoreceptor degeneration resulting from |
|
||
contribute to approximately 50% of newly formed |
|
||
genetic and other factors is a leading and largely |
|
||
vasculature in CN. Sengupta N et al have shown that |
|
||
untreatable cause of blindness worldwide. The object |
|
||
stromal-derived factor (SDF)-1 is involved with homing |
|
||
of this study was to find a cell type that is effective |
|
||
of HSCs from bone marrow to target tissue. Vascular |
|
||
in slowing the progress of such degeneration in an |
|
||
endothelial cadherin (VE-cadherin, or CD144) is |
|
||
animal model of human retinal disease, is safe and |
|
||
involved in endothelial cell adhesion. Preventing |
|
||
could be generated in sufficient numbers for clinical |
|
||
homing and/or adhesion of progenitor cells to |
|
||
application. We have compared efficacy of four |
|
||
damaged choroid could reduce CNV. |
|
||
human-derived cell types in preserving photoreceptor |
|
||
METHODS: Adult C57BL/6J mice. |
|
||
integrity and visual functions after injection into the |
|
||
|
|
|
|
subretinal space of the Royal College of Surgeons rat |
RESULTS: CNV lesions from eyes treated with anti- |
|
|
early in the progress of degeneration. Umbilical tissue- |
CD144 showed significantly less incorporation of gfp+ |
|
|
|
|
|
|
